Riskpilot← Back to searchSign inGet full accessSMARTFISH AS
ASActiveOrg 983032958Mustads Vei 1A, 0283 OsloManufacture of homogenised food preparations and dietetic food · NACE 1086Est. 20014 employeeswww.smartfish.no
Revenue 2024
NOK 17,1M
+2% vs 2023
EBITDA margin
28.2%
+144% vs 2023
Equity ratio
-10.3%
Financial strength
Net profit 2024
NOK 4,5M
+138% vs 2023
| Revenue | NOK 17,1M | +2% |
| EBITDA | NOK 4,8M | +144% |
| Net profit | NOK 4,5M | +138% |
| Total assets | NOK 4,4M | -46% |
| Equity | NOK -451K | +96% |
| Employees | 4 | — |
Legal name
SMARTFISH AS
Org number
983032958
Legal form
Aksjeselskap
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
19. februar 2001
Share capital
NOK 4 201 114
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder i fellesskap med daglig leder eller ett styremedlem.
Company purpose
Produksjon, salg, markedsføring og distribusjon av varer og tjenester innen matvare. Helost og legemiddel-bransjen og det som naturlig knytter seg til dette.
Address
Mustads Vei 1A, 0283 Oslo
Website
www.smartfish.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 890 | 4 762 | 5 951 | 4 852 | 5 146 | 6 787 | 9 221 | 14 934 | 27 648 | 19 454 | 18 205 | 16 673 | 14 849 | 13 256 | 12 714 | 16 685 | 17 078 |
| Staff expenses | −3 401 | −3 720 | −2 960 | −5 221 | −6 643 | −7 960 | −9 185 | −8 702 | −10 768 | −11 895 | −0 | −0 | −6 901 | −7 162 | −1 679 | −3 253 | −0 |
| EBITDA | −10 998 | −8 413 | −4 981 | −9 948 | −11 339 | −14 646 | −20 712 | −30 199 | −34 937 | −27 263 | −25 492 | −27 151 | −23 699 | −24 005 | −15 949 | −10 921 | 4 823 |
| Depreciation & amort. | −9 | −16 | −28 | −46 | −99 | −116 | −78 | −47 | −47 | −40 | −50 | −564 | −225 | −27 | −24 | −18 | −368 |
| EBIT | −11 008 | −8 429 | −5 009 | −9 994 | −11 438 | −14 761 | −20 790 | −30 246 | −34 984 | −27 304 | −25 542 | −27 715 | −23 924 | −24 032 | −15 973 | −10 939 | 4 455 |
| Net financials | −83 | −384 | −472 | 785 | −1 493 | −1 273 | 310 | −679 | −240 | −190 | −1 968 | −5 080 | 2 812 | 213 | −438 | −919 | 14 |
| Profit before tax | −11 091 | −8 813 | −5 481 | −9 209 | −12 932 | −16 035 | −20 480 | −30 925 | −35 224 | −27 493 | −27 510 | −32 795 | −21 112 | −23 819 | −16 410 | −11 859 | 4 469 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −11 091 | −8 813 | −5 481 | −9 209 | −12 932 | −16 035 | −20 480 | −30 925 | −35 224 | −27 493 | −27 510 | −32 795 | −21 112 | −23 819 | −16 410 | −11 859 | 4 469 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 921 | 3 536 | 3 788 | 7 517 | 5 224 | 21 345 | 25 887 | 37 650 | 17 400 | 19 445 | 17 510 | 61 106 | 52 981 | 30 361 | 9 582 | 8 059 | 4 367 |
| Equity | −3 873 | −6 336 | −11 818 | 2 067 | −10 865 | 15 370 | 18 540 | 28 434 | 6 460 | 12 217 | −12 591 | 35 961 | 28 737 | 4 997 | −11 414 | −10 788 | −451 |
| Long-term debt | 179 | 0 | 0 | 0 | 1 765 | 1 471 | 1 176 | 882 | 588 | 294 | 0 | 15 930 | 15 402 | 13 401 | 13 401 | 12 182 | 1 100 |
| Short-term debt | 7 614 | 7 266 | 9 078 | 3 391 | 14 324 | 4 504 | 6 171 | 8 334 | 10 352 | 6 934 | 30 103 | 9 215 | 8 843 | 11 963 | 7 595 | 6 665 | 3 718 |
| Total debt | 7 793 | 9 872 | 15 606 | 5 450 | 16 089 | 5 974 | 7 347 | 9 216 | 10 940 | 7 228 | 30 103 | 25 145 | 24 245 | 25 364 | 20 996 | 18 847 | 4 818 |
EBITDA margin
28.2%
This company
15.8%
Market median
+78% vs market
20082024
Equity ratio
-10.3%
This company
38.2%
Market median
-127% vs market
20082024
Return on equity
446902900.0%
This company
18.4%
Market median
+2428820009% vs market
20082024
Net profit margin
26.2%
This company
8.1%
Market median
+223% vs market
20082024
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20082024
Debt / equity
10.69×
This company
0.62×
Market median
-1624% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JO Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
GH Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Immunopharma As | Company | 100.0% | 100.0% | 2024 |
Investinor Direkte As | Company | 38.7% | 38.7% | 2023 |
Stiftelsen Industrifonden | Company | 32.6% | 32.6% | 2023 |
| Individual | 28.6% | 28.6% | 2022 | |
Jolly Harvest Inc | Company | 8.7% | 8.7% | 2023 |
Bjørn Bergvall As | Company | 5.4% | 5.4% | 2023 |
Jsl As | Company | 2.2% | 2.2% | 2023 |
Mittas As | Company | 2.1% | 2.1% | 2023 |
| Individual | 1.1% | 1.1% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SMARTFISH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olsson | Chief Executive Officer | 0 companies |
| Geir Harstad | Chief Executive Officer | 0 companies |
| Jonas Jendi | Chairman | 0 companies |
| Benedicte Heidenreich Fossum | Chairman | 0 companies |
| Roar Arnstad | Board of Directors | 0 companies |
| Per Ivar Lund | Chairman | 0 companies |
| Iacob Mathiesen | Board of Directors | 0 companies |
| Knut Christian Espeseth | Chairman | 0 companies |
| Karin Judith Meyer | Board of Directors | 0 companies |
| Kjetil Ramsøy | Chairman | 0 companies |
| Ronny Vikdal | Board of Directors | 0 companies |